IndraLab

Statements


| 1

sparser
"Interestingly, these loci have begun to implicate pathways: in addition to at least one target of current neuropharmacology (the dopamine receptor DRD2) , for the first time, critical glutamatergic genes such as GRM3 and GRIN2A, and calcium channel subunits ( CACNA1C and CACNA1l ) have been associated with SZ."